Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am wondering if the press release regarding Stallergenes Greer simply means that there will be no deal with Anergis until December.
Bei Anergis steht bis spätestens Dezember eine Entscheidung an, und wegen dem Malaria- und HIV-Programm sollen wohl auch noch in diesem Jahr Ergebnisse kommen.
TheHungryHippo hat hier https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150345990 eine schöne Zusammenfassung geschrieben.
Ein fertiges Produkt hat Mymetics natürlich nicht auf dem Markt, aber das wäre ja auch angesichts der Art der Produkte und bei dieser Marktkapitalisierung zu viel verlangt, oder?
Was macht Dich denn so sicher in Deinen Äußerungen?
Klar, ich bin auch nicht gerade davon begeistert, wenn Beiträge vor Optimismus in Großbuchstaben überquellen, aber immerhin sollten in diesem Jahr noch drei wesentliche Nachrichten kommen, bei denen ich eher mit positivem rechne. Aber ich weiß natürlich auch nichts, nur frage ich mich, was Leute - sei es im Positiven oder Negativen - so sicher sein lässt.
Who's so cruel to me?
Such an action, but I don't see any news.
I think that's too optimistic and could lead to disappointment. The NT 10-Q said: "Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year willbe reflected by the earnings statements to be included in the subject report or portion thereof? [ ]Yes [X]No"
@Staypositive1: Thank you very much for your message!
I think we can expect to get at least three more PRs this year. Should be an interesting autumn.
Thank you!
That makes sense.
And it's a good sign. Hopefully the 10-Q is not far anymore.
There's a new OTCQB Certification available at otcmarkets.com.
ASNB changed from
"Company is registered under Section 12(g) of the Exchange Act"
to
"Company is reporting under Section 15(d) of the Exchange Act"
And at item (f) a financial consultant is mentioned - seems to be the first time.
What does that mean?
I conject it takes more time to do calculations with positive numbers (profits) than with negative ones.
I didn't read the 10-K completely, but couldn't find any reason for the non-timely filing.
By the way: in my opinion share price is by far too low.
If ASNB would be a start-up with such a product, I think it would be valued above 10M market-cap.
I did not reckon with a filing until today. But putting a sentence like "The subject quarterly report on Form 10-Q will be filed on or before the fifth (5 th ) calendar day following the prescribed due date of August 14, 2019." in the NT, while the last filing is strongly in delay, and again not releasing anything, is something that's not easy for me to express in English.
I am wondering what the plan behind this is.
"[...] Anergis has now a time limited exclusive option until December 2019 to enter into a License and Collaboration Agreement [...]"
I am curious if we will get a 10-Q - it's due on Wednesday.
Since a audit should not be necessary for it, they simply could file it, but I don't know if they are allowed to skip the 10-K in this way.
That would give some hints about the reason they did not file the 10-K.
In my opinion the only reason for being that late is the difficulty of a merger. But I would prefer a buyout and decline bankrupcy.
Yes, I read that, but it sounds expensive to me.
Nevertheless I would like that, because it would mean our company has a big value. And the product is excellent.
I can't believe, that the price is really 160$ per catheter.
If I remember correctly, the price for our product increases with the number of days without infection. I did search for that, but unfortunately I couldn't find it anymore - is it at about 10 cent/catheter?
But I absolutely don't know about the percentage, since I don't understand, what quantity the price of $1,661.94 USD is at that site for:
https://www.graylinemedical.com/products/powerwand-midline-catheters-by-access-scientific?variant=19413807464505
Thank you very much for the excellent work!
Yes, thanks!
I will be waiting patiently until ASNB announces the effect.
Shouldn't they mention this as a major event after compilation of the report? - From time to time I am reading such formulations.
Thanks for the link!
I am surprised to read that the $20M is "To expand marketing and sales of POWERWAND...". That's much money for that.
In the 10-K we should get an outlook on that.
At Yahoo, there are "news", BUT ATTENTION: They linked news for MYM to MYMX. Perhaps that's the reason?
Are we preparing for Anergis news? ;-(
Tomorrow in two weeks the 10-Q is already due.
I sent two emails because of the 10-K - unfortuantely no answer.
"Anergis investor Sunstone Capital is freeing up $332
million in funds."
SEK 1 is not $1!
SEK 332M = USD 34.94M
Thank you!
Regarding share count I was wrong:
outstanding (from otcmarkets.com): 21567313
options 08/17/2017 (from last 10-Q): 5600000
options 08/16/2018 (from last 10-Q): 750000
= 27917313
Sorry for my ignorance: Does anyone know if we would need to vote in case of a sale or merger? I think, after execution of all stock options there should be about 32M shares outstanding with perhaps 30% in hands of CEO and employees. Could they decide alone?
It seems strange to me.
According to the NT there will be no significant change in results, and as far as I remember from PRs and earlier reports there's nothing special going on that could take influence to the report in a way it could take much more time.
We do own a very small company; perhaps it's such simple that someone needed for compiling the report is ill.
I am also thinking about a sale of the company, but I really don't know if that could be a reason to hold back the report.
Only speculation, but I am worried.
Thanks for the update!
Any news?
I sent an e-mail to the company because of the delay. But so far I haven't received an answer. Someone else?
I didn't notice the switch of accounting firm. But I don't think that's the reason for being late, because the NT says:
"The Registrant was unable, without unreasonable effort and expense, to prepare its accounting records and schedules in sufficienttime to enable its independent registered public accounting firm to complete its annual audit of the Registrant ’ s financialstatements to be contained in its Annual Report on Form 10-K for the year ended March 31, 2019 on or before June 29, 2019."
I think they would give the correct reason therein if it's because of such a switch.
Hopefully it's not something bad. According to the NT results should not be a surprise.
Thank you, Staypositive1!
It's already July and still nothing about Anergis. Frankly spoken I don't count anymore on the Anergis deal. I am really disappointed. First the big disappointment with Sanofi and now my hope for Anergis is actually lost.
Once I did send a mail to the company asking about how long the "time limited exclusive option" lasts, as well as suggesting to PR that, but I didn't get an answer.
I suspect there is a strategy behind this lack of information: Not to release information as long as possible keeps the share price up, until we get new hope in this or that when we get the bad information in a subordinate clause of a 10-Q/K.
I will not sell these days, but every day holding I am wondering more and more, what we actually own.
In just over a month we should see the 10-Q. I am guessing there will be nothing positive in it.
Unfortunately I am not anymore an optimist.
Thanks for clarification!
I expected it mid last week. Maybe I am missing something, but I think 90 days are over.
Perhaps they are busy counting money.
I see a bid of about 6000000, in words: six million, shares.
I think, last PR was in Sept. 2018:
https://finance.yahoo.com/news/advansource-biomaterials-announces-multi-extension-183000439.html
But nevertheless the company seems to me to be too silent. Since our product should be good, I think it's possible to see a buyout. At least I do hope so.
After reading the latest RR it seems to me:
1. Staff of Mymetics is reading here.
2. Mymetics has nothing to do with RTS,S.